Filing Details
- Accession Number:
- 0001140361-12-052005
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-12-19 20:30:08
- Reporting Period:
- 2012-12-17
- Filing Date:
- 2012-12-19
- Accepted Time:
- 2012-12-19 20:30:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 711665 | Photomedex Inc | PHMD | Electromedical & Electrotherapeutic Apparatus (3845) | 592858100 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1269340 | M Dennis Mcgrath | Photomedex, Inc. 147 Keystone Drive Montgomeryville PA 18936 | President & Cfo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Photomedex Common Stock | Disposition | 2012-12-17 | 50,500 | $14.34 | 251,556 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The transactions reported on this Form 4 were effected pursuant to a 10b5-1 Trading Plan adopted by the reporting person on June 11, 2012 under the Securities Exchange Act of 1934, providing for the periodic sales of Common Stock of PhotoMedex, Inc. pursuant to Rule 144. Such shares were sold to pay estimated income taxes applicable as a result of the vesting of such shares, pursuant to the terms of the 10b5-1 Trading Plan.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.11 to $14.59, inclusive. The reporting person undertakes to provide to PhotoMedex, Inc., any security holder of PhotoMedex Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
Billionaire Hedge Funds
